Recombinant Protein Therapeutics Market - Global Outlook and Forecast 2021-2027

April 2021 | 91 pages | ID: RD1DB03F238DEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Recombinant Protein Therapeutics in Global, including the following market information:

Global Recombinant Protein Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Recombinant Protein Therapeutics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Protein Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Protein Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Recombinant Protein Therapeutics Market Segment Percentages, By Type, 2020 (%)

• Recombinant Hormones
• Interferons
• Interleukins
• Hematopoietic Growth Factors
• Others

China Recombinant Protein Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Recombinant Protein Therapeutics Market Segment Percentages, By Application, 2020 (%)

• Diabetes
• Dwarfism
• Heart Disease
• Cancer
• Others

Global Recombinant Protein Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Recombinant Protein Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Recombinant Protein Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Recombinant Protein Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Eli Lilly
• Pfizer
• Merck
• Roche
• Biogen
• Bayer
• J&J
• Amgen
• Sanofi
• Ligand

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Recombinant Protein Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Recombinant Protein Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RECOMBINANT PROTEIN THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Recombinant Protein Therapeutics Market Size: 2021 VS 2027
2.2 Global Recombinant Protein Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Recombinant Protein Therapeutics Players in Global Market
3.2 Top Global Recombinant Protein Therapeutics Companies Ranked by Revenue
3.3 Global Recombinant Protein Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Protein Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Recombinant Protein Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Protein Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Recombinant Protein Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Recombinant Protein Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Recombinant Protein Therapeutics Market Size Markets, 2021 & 2027
  4.1.2 Recombinant Hormones
  4.1.3 Interferons
  4.1.4 Interleukins
  4.1.5 Hematopoietic Growth Factors
  4.1.6 Others
4.2 By Type - Global Recombinant Protein Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Recombinant Protein Therapeutics Revenue, 2016-2021
  4.2.2 By Type - Global Recombinant Protein Therapeutics Revenue, 2022-2027
  4.2.3 By Type - Global Recombinant Protein Therapeutics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Recombinant Protein Therapeutics Market Size, 2021 & 2027
  5.1.2 Diabetes
  5.1.3 Dwarfism
  5.1.4 Heart Disease
  5.1.5 Cancer
  5.1.6 Others
5.2 By Application - Global Recombinant Protein Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Recombinant Protein Therapeutics Revenue, 2016-2021
  5.2.2 By Application - Global Recombinant Protein Therapeutics Revenue, 2022-2027
  5.2.3 By Application - Global Recombinant Protein Therapeutics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Recombinant Protein Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Recombinant Protein Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Recombinant Protein Therapeutics Revenue, 2016-2021
  6.2.2 By Region - Global Recombinant Protein Therapeutics Revenue, 2022-2027
  6.2.3 By Region - Global Recombinant Protein Therapeutics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Recombinant Protein Therapeutics Revenue, 2016-2027
  6.3.2 US Recombinant Protein Therapeutics Market Size, 2016-2027
  6.3.3 Canada Recombinant Protein Therapeutics Market Size, 2016-2027
  6.3.4 Mexico Recombinant Protein Therapeutics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Recombinant Protein Therapeutics Revenue, 2016-2027
  6.4.2 Germany Recombinant Protein Therapeutics Market Size, 2016-2027
  6.4.3 France Recombinant Protein Therapeutics Market Size, 2016-2027
  6.4.4 U.K. Recombinant Protein Therapeutics Market Size, 2016-2027
  6.4.5 Italy Recombinant Protein Therapeutics Market Size, 2016-2027
  6.4.6 Russia Recombinant Protein Therapeutics Market Size, 2016-2027
  6.4.7 Nordic Countries Recombinant Protein Therapeutics Market Size, 2016-2027
  6.4.8 Benelux Recombinant Protein Therapeutics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Recombinant Protein Therapeutics Revenue, 2016-2027
  6.5.2 China Recombinant Protein Therapeutics Market Size, 2016-2027
  6.5.3 Japan Recombinant Protein Therapeutics Market Size, 2016-2027
  6.5.4 South Korea Recombinant Protein Therapeutics Market Size, 2016-2027
  6.5.5 Southeast Asia Recombinant Protein Therapeutics Market Size, 2016-2027
  6.5.6 India Recombinant Protein Therapeutics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Recombinant Protein Therapeutics Revenue, 2016-2027
  6.6.2 Brazil Recombinant Protein Therapeutics Market Size, 2016-2027
  6.6.3 Argentina Recombinant Protein Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Recombinant Protein Therapeutics Revenue, 2016-2027
  6.7.2 Turkey Recombinant Protein Therapeutics Market Size, 2016-2027
  6.7.3 Israel Recombinant Protein Therapeutics Market Size, 2016-2027
  6.7.4 Saudi Arabia Recombinant Protein Therapeutics Market Size, 2016-2027
  6.7.5 UAE Recombinant Protein Therapeutics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Recombinant Protein Therapeutics Major Product Offerings
  7.1.4 Eli Lilly Recombinant Protein Therapeutics Revenue in Global (2016-2021)
  7.1.5 Eli Lilly Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Recombinant Protein Therapeutics Major Product Offerings
  7.2.4 Pfizer Recombinant Protein Therapeutics Revenue in Global (2016-2021)
  7.2.5 Pfizer Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Recombinant Protein Therapeutics Major Product Offerings
  7.3.4 Merck Recombinant Protein Therapeutics Revenue in Global (2016-2021)
  7.3.5 Merck Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Recombinant Protein Therapeutics Major Product Offerings
  7.4.4 Roche Recombinant Protein Therapeutics Revenue in Global (2016-2021)
  7.4.5 Roche Key News
7.5 Biogen
  7.5.1 Biogen Corporate Summary
  7.5.2 Biogen Business Overview
  7.5.3 Biogen Recombinant Protein Therapeutics Major Product Offerings
  7.5.4 Biogen Recombinant Protein Therapeutics Revenue in Global (2016-2021)
  7.5.5 Biogen Key News
7.6 Bayer
  7.6.1 Bayer Corporate Summary
  7.6.2 Bayer Business Overview
  7.6.3 Bayer Recombinant Protein Therapeutics Major Product Offerings
  7.6.4 Bayer Recombinant Protein Therapeutics Revenue in Global (2016-2021)
  7.6.5 Bayer Key News
7.7 J&J
  7.7.1 J&J Corporate Summary
  7.7.2 J&J Business Overview
  7.7.3 J&J Recombinant Protein Therapeutics Major Product Offerings
  7.4.4 J&J Recombinant Protein Therapeutics Revenue in Global (2016-2021)
  7.7.5 J&J Key News
7.8 Amgen
  7.8.1 Amgen Corporate Summary
  7.8.2 Amgen Business Overview
  7.8.3 Amgen Recombinant Protein Therapeutics Major Product Offerings
  7.8.4 Amgen Recombinant Protein Therapeutics Revenue in Global (2016-2021)
  7.8.5 Amgen Key News
7.9 Sanofi
  7.9.1 Sanofi Corporate Summary
  7.9.2 Sanofi Business Overview
  7.9.3 Sanofi Recombinant Protein Therapeutics Major Product Offerings
  7.9.4 Sanofi Recombinant Protein Therapeutics Revenue in Global (2016-2021)
  7.9.5 Sanofi Key News
7.10 Ligand
  7.10.1 Ligand Corporate Summary
  7.10.2 Ligand Business Overview
  7.10.3 Ligand Recombinant Protein Therapeutics Major Product Offerings
  7.10.4 Ligand Recombinant Protein Therapeutics Revenue in Global (2016-2021)
  7.10.5 Ligand Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Recombinant Protein Therapeutics Market Opportunities & Trends in Global Market
Table 2. Recombinant Protein Therapeutics Market Drivers in Global Market
Table 3. Recombinant Protein Therapeutics Market Restraints in Global Market
Table 4. Key Players of Recombinant Protein Therapeutics in Global Market
Table 5. Top Recombinant Protein Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Recombinant Protein Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Recombinant Protein Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Recombinant Protein Therapeutics Product Type
Table 9. List of Global Tier 1 Recombinant Protein Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Protein Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Recombinant Protein Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Recombinant Protein Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Recombinant Protein Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Recombinant Protein Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Recombinant Protein Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Recombinant Protein Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Recombinant Protein Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Recombinant Protein Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Recombinant Protein Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Recombinant Protein Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Recombinant Protein Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Recombinant Protein Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Recombinant Protein Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Recombinant Protein Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Recombinant Protein Therapeutics Product Offerings
Table 32. Eli Lilly Recombinant Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Recombinant Protein Therapeutics Product Offerings
Table 35. Pfizer Recombinant Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Merck Corporate Summary
Table 37. Merck Recombinant Protein Therapeutics Product Offerings
Table 38. Merck Recombinant Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Roche Corporate Summary
Table 40. Roche Recombinant Protein Therapeutics Product Offerings
Table 41. Roche Recombinant Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Biogen Corporate Summary
Table 43. Biogen Recombinant Protein Therapeutics Product Offerings
Table 44. Biogen Recombinant Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Bayer Corporate Summary
Table 46. Bayer Recombinant Protein Therapeutics Product Offerings
Table 47. Bayer Recombinant Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. J&J Corporate Summary
Table 49. J&J Recombinant Protein Therapeutics Product Offerings
Table 50. J&J Recombinant Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. Amgen Corporate Summary
Table 52. Amgen Recombinant Protein Therapeutics Product Offerings
Table 53. Amgen Recombinant Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Sanofi Corporate Summary
Table 55. Sanofi Recombinant Protein Therapeutics Product Offerings
Table 56. Sanofi Recombinant Protein Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Ligand Corporate Summary
Table 58. Ligand Recombinant Protein Therapeutics Product Offerings
Table 59. Ligand Recombinant Protein Therapeutics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Protein Therapeutics Segment by Type
Figure 2. Recombinant Protein Therapeutics Segment by Application
Figure 3. Global Recombinant Protein Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Recombinant Protein Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Recombinant Protein Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Protein Therapeutics Revenue in 2020
Figure 8. By Type - Global Recombinant Protein Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Recombinant Protein Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Recombinant Protein Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Recombinant Protein Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Recombinant Protein Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Recombinant Protein Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Recombinant Protein Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Recombinant Protein Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Recombinant Protein Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Eli Lilly Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Merck Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Roche Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Biogen Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bayer Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. J&J Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Amgen Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sanofi Recombinant Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)